Cell harvesting is crucial to the cell therapy manufacturing process, bridging the gap between cells’ optimized growth environment and a final formulation that retains their potency and efficacy. The number of variables that impact harvesting, coupled with the complexities introduced by the unique CQAs of each cell therapy and the fragility of many emerging cell types, can result in a challenging balancing act that requires significant expertise to navigate.
The cell harvesting step is of utmost importance for cell therapy manufacturers. During this step, high cell viability and recovery are important to maximize yield. Single-use, low shear closed-system centrifuges enable safe and efficient cell therapy manufacturing through the efficient recovery of viable cells.
Cultivated meat cells can be collected with single-use centrifuges including the UFMini, UniFuge Pilot, and the U2k. The CARR Biosystems tubular bowl design offers several advantages. Download this case study to learn more.
Get in touch with a sales representative, request support or download our free white paper.